The clinical use of diphenylhydantoin (Dilantin) in the treatment and prevention of cardiac arrhythmias
- 31 March 1969
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 77 (3), 315-323
- https://doi.org/10.1016/0002-8703(69)90187-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Use of diphenylhydantoin sodium to dissociate the effects of procainamide on automaticity and conduction in the normal and arrhythmic heartThe American Journal of Cardiology, 1967
- The Current Status of Diphenylhydantoin in Heart DiseaseAnnals of Internal Medicine, 1967
- Cardiac Arrhythmias during AnesthesiaDiseases of the Chest, 1967
- Coxsackievirus and Congenital MalformationPublished by American Medical Association (AMA) ,1967
- Protection from Digitalis Toxicity with the Prophylactic Use of Diphenylhydantoin Sodium An Arrhythmic-Inotropic DissociationCirculation, 1967
- Cardiac Arrhythmias in Acute Myocardial Infarction II. Incidence of the Common Arrhythmias with Special Reference to Ventricular TachycardiaDiseases of the Chest, 1967
- Intravenous Diphenylhydantoin Sodium (Dilantin) in Cardiac ArrhythmiasDiseases of the Chest, 1967
- Digitalis toxicity. Treatment with diphenylhydantoinArchives of Internal Medicine, 1965
- Sodium Diphenylhydantoin in the Treatment of Recurrent Cardiac ArrhythmiasJAMA, 1965
- CARDIAC ARRHYTHMIAS IN RELATIONSHIP TO ANESTHESIAThe American Journal of the Medical Sciences, 1962